Literature DB >> 10919373

Nerve growth factor-potentiating compounds from Picrorhizae Rhizoma.

P Li1, K Matsunaga, Y Ohizumi.   

Abstract

A crude methanol extract of Picrorhizae Rhizoma, the dried underground parts of Picrorhiza scrophulariiflora PENNELL, has been shown to potentiate the nerve growth factor (NGF)-induced neurite outgrowth from PC12D cells. The methanol extract was partitioned between ethyl acetate and water. The NGF-potentiating activity was observed in the ethyl acetate fraction. The ethyl acetate solubles were fractionated by silica gel chromatography, monitoring the NGF-potentiating activity to give two iridoid glycosides, picrosides I and II. Picrosides did not exhibit neurotrophic activity but caused a marked enhancement of the NGF-mediated neurite outgrowth from PC12D cells. The pharmacological data suggest that picrosides I and II enhance neurite outgrowth from PC12D cells, probably by amplifying a step in the NGF-receptor-mediated intracellular signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919373     DOI: 10.1248/bpb.23.890

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Picroside II Protects Rat Lung and A549 Cell Against LPS-Induced Inflammation by the NF-κB Pathway.

Authors:  Bingyu Shen; Chenxu Zhao; Chengzhen Chen; Zheng Li; Yang Li; Ye Tian; Haihua Feng
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

Review 2.  Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update.

Authors:  Roohi Mohi-Ud-Din; Reyaz Hassan Mir; Abdul Jalil Shah; Saba Sabreen; Taha Umair Wani; Mubashir Hussain Masoodi; Esra Küpeli Akkol; Zulfiqar Ali Bhat; Haroon Khan
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

3.  Neutrophilic Lung Inflammation Suppressed by Picroside II Is Associated with TGF-β Signaling.

Authors:  Soohwan Noh; Kyung-Seop Ahn; Sei-Ryang Oh; Kyun Ha Kim; Myungsoo Joo
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-05       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.